945632-75-7 Usage
General Description
1(2H)-Naphthalenone, 3,4-dihydro-6-octyl- is a chemical compound with the molecular formula C18H24O. It is a synthetic organic compound that is commonly used as a fragrance ingredient in various personal care products, including perfumes, lotions, and soaps. It is also used in some insect repellents and as a flavoring agent in food products. The chemical is a pale yellow to brownish liquid with a strong, musky odor and is known to have skin sensitizing properties, and for this reason, it is important for individuals to be cautious when using products containing this compound. Additionally, it is important to follow safety guidelines and regulations when handling and disposing of this chemical to prevent harm to human health and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 945632-75-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,5,6,3 and 2 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 945632-75:
(8*9)+(7*4)+(6*5)+(5*6)+(4*3)+(3*2)+(2*7)+(1*5)=197
197 % 10 = 7
So 945632-75-7 is a valid CAS Registry Number.
945632-75-7Relevant articles and documents
Stereochemistry-activity relationship of orally active tetralin S1P agonist prodrugs
Ma, Bin,Guckian, Kevin M.,Lin, Edward Yin-Shiang,Lee, Wen-Cherng,Scott, Daniel,Kumaravel, Gnanasambandam,Macdonald, Timothy L.,Lynch, Kevin R.,Black, Cheryl,Chollate, Sowmya,Hahm, Kyungmin,Hetu, Gregg,Jin, Ping,Luo, Yi,Rohde, Ellen,Rossomando, Anthony,Scannevin, Robert,Wang, Joy,Yang, Chunhua
scheme or table, p. 2264 - 2269 (2010/07/05)
Modifying FTY720, an immunosuppressant modulator, led to a new series of well phosphorylated tetralin analogs as potent S1P1 receptor agonists. The stereochemistry effect of tetralin ring was probed, and (-)-(R)-2-amino-2-((S)-6-octyl-1,2,3,4-tetrahydrona
BICYCLIC SPHINGOSINE 1-PHOSPHATE ANALOGS
-
Page/Page column 30, (2008/06/13)
Compounds that have agonist activity at one or more of the S1P receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S1P receptors.
